Sanara Medtech Inc at Piper Sandler Healthcare Conference Transcript
All right. Small, intimate group here. Well, good to meet everybody. I am Zach Fleming. I am the CEO of Samara MedTech, traded on NASDAQ, SMTI. A little background on me: I came up through the wound care space, started in the wound care space, Healthpoint, and then got acquired by Smith & Nephew back in 2012 and then ran up through some leadership opportunities in Smith & Nephew, and then came here in 2017. It's been a really fun ride.
Before I get started, these are our disclaimers, [like most companies have their disclaimers]. All of these are statements that could have risks to them. We are based out of Fort Worth, Texas. We were a $303 million market cap as of November 25. In Q3 we generated 124% growth compared to the prior year.
And the way we are set up, we have two divisions: there is a surgical division, and it drives a lot of revenue for us today. It's a very big focus for us. And then in the future, we intend to do more around the comprehensive wound and skin spaces. And that's in the post-acute setting. That will launch fully
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
